The number of times each genomic character is read is an important parameter of test quality. Our tests read each relevant character 400 times on average, to ensure accuracy.

Because of our exquisite coverage and our long history of bioinformatics, we can call genomic variants that span several hundreds or even thousands of genomic characters very effectively.

Our bioinformatics platforms built completely in house have been at work for over a decade to allow accurate identification of the relevant variants. Many tens or hundreds of variants that are found are carefully examined in the light of scientific evidence for their role in cancer risk, using the criteria laid out by guidelines from the American College of Medical Genetics. Those that reach the evidence level of Pathogenic or Likely Pathogenic are reported along with those that carry considerable uncertainty, i.e. Variants of Unknown Significance.